Literature DB >> 8554655

Neurologic manifestations of pediatric systemic lupus erythematosus.

M I Steinlin1, S I Blaser, D L Gilday, A A Eddy, W J Logan, R M Laxer, E D Silverman.   

Abstract

Central nervous system involvement is a common but rarely reviewed feature of pediatric systemic lupus erythematosus (SLE). We retrospectively reviewed the charts of 91 patients with pediatric SLE and using a standardized data abstraction form documented 40 patients with central nervous system (CNS-SLE) involvement. The mean age of onset of SLE was 13.3 years. In 19 patients the CNS manifestation was a presenting symptom, in 12 patients CNS involvement was present within the first year of diagnosis, and in 9 patients it took up to 7 years for CNS disease to become evident. Nineteen children (48%) manifested neuropsychiatric SLE, which included depression, concentration or memory problems, and frank psychosis. Seizures were present in 8 patients (20%), 6 had cerebral ischemic events (15%), 1 had chorea (3%), 2 had papilledema (5%), and 2 patients had a peripheral neuropathy (5%). Nine patients (22%) had severe headache consistent with lupus headache. Seven children had more than one CNS manifestation. In the investigation of CNS-SLE, computed tomography and/or magnetic resonance imaging scans were helpful in patients with focal ischemic lesions and venous sinus thrombosis. Electroencephalography was abnormal only in 33% of patients with seizure disorders and rarely helpful in patients with diffuse neuropsychiatric symptoms. Single-photon emission computed tomography scans were abnormal in most patients with neuropsychiatric SLE, especially in those with frank psychosis. The lupus anticoagulant was present in the patient with chorea and was frequently present in patients with cerebral vascular events. Long-term outcome was good: only 1 child died of cerebral hemorrhagic infarction and 3 others had significant persistent CNS deficits. The majority of patients (90%) had excellent recovery from CNS-SLE.

Entities:  

Mesh:

Year:  1995        PMID: 8554655     DOI: 10.1016/0887-8994(95)00110-2

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  18 in total

1.  Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?

Authors:  Rina Mina; Hermine I Brunner
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 2.  Ischemic strokes in children.

Authors:  L E Walsh; B P Garg
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

3.  Neurocognitive impairment in childhood-onset systemic lupus erythematosus: measurement issues in diagnosis.

Authors:  Tricia S Williams; Cynthia Aranow; Gail S Ross; Alexandra Barsdorf; Lisa F Imundo; Andrew H Eichenfield; Philip J Kahn; Betty Diamond; Deborah M Levy
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-08       Impact factor: 4.794

4.  Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience.

Authors:  Afshin Borhani Haghighi; Shahab Ghasem Haza
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383

5.  Is there a need for ophthalmological examinations after a first seizure in paediatric patients?

Authors:  Matthias K Bernhard; Alexandra Gläser; Kathrin Ulrich; Andreas Merkenschlager
Journal:  Eur J Pediatr       Date:  2009-03-07       Impact factor: 3.183

6.  Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus.

Authors:  Mohamed O Olfat; Sulaiman M Al-Mayouf; Mohamed A Muzaffer
Journal:  Clin Rheumatol       Date:  2004-07-23       Impact factor: 2.980

7.  Chronic inflammatory demyelinating polyradiculoneuropathy in a boy with systemic lupus erythematosus.

Authors:  Morel Ayala Zoilo; Benadón Eduardo; Faugier Enrique; Maldonado V M del Rocio
Journal:  Rheumatol Int       Date:  2009-06-18       Impact factor: 2.631

Review 8.  Vasculitis in children and adolescents: clinical presentation, etiopathogenesis, and treatment.

Authors:  Kjell Tullus; Stephen D Marks
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

9.  Hemichorea with antiphospholipid antibodies in a patient with lupus nephritis.

Authors:  Toru Watanabe; Hiroo Onda
Journal:  Pediatr Nephrol       Date:  2004-01-23       Impact factor: 3.714

10.  Epilepsy associated with systemic autoimmune disorders.

Authors:  Orrin Devinsky; Adam Schein; Souhel Najjar
Journal:  Epilepsy Curr       Date:  2013-03       Impact factor: 7.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.